DE40: DAX still close to ATH zone 🔔German defense stocks under pressure

2:29 PM 6 June 2025

The German equity market is once again showing resilience – effectively withstanding selling pressure. The DAX spot index has recovered part of its earlier losses and is down only 0.18%, while DE40 futures are posting modest gains in the 0.3–0.4% range ahead of key U.S. macroeconomic data (NFP report at 12:30 PM GMT). The pullback in German defense stocks such as Rheinmetall, RENK, and Hensoldt appears to be driven mainly by profit-taking after previous rallies.

  • Fraport and space-laser company Mynaric lead gains on the German stock market
  • Shares of Fraport and Mynaric are leading the list of gainers on the German stock exchange. In contrast, defense companies such as Rheinmetall, RENK Group, and Hensoldt are trading lower, with losses ranging from -1.5% to -3%. Nevertheless, according to Bloomberg, German defense firms continue to show stronger earnings momentum than their American counterparts.
  • Tesla ADRs (TSLA.DE) are down over 7% today, extending yesterday’s sell-off.
  • Eurozone GDP revision came in above expectations, and retail sales surprised to the upside on a year-over-year basis, although they slightly missed forecasts month-over-month.

There have been no significant developments that would directly weaken sentiment toward the German defense sector. Yesterday, Chancellor Friedrich Merz met with Donald Trump – both leaders expressed their intention to strengthen transatlantic cooperation, although details of the talks have not been disclosed. Trump received an invitation to visit Germany, and the main topics discussed were trade, the G7, and NATO.

DE40 (Daily Interval)
The key resistance level for the DE40 index, based on price action analysis, is currently around 24,500 points. Important support lies in the 23,600-point area.

Source: xStation5

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Share:
Back

Join over 1 600 000 investors from around the world